Ross, A. H., Donachie, P. H. J., Sallam, A., Stratton, I. M., Mohamed, Q., Scanlon, P. H., . . . Johnston, R. L. (2013). Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab? Nature Publishing Group.

Ross, A H., P H J. Donachie, A. Sallam, I M. Stratton, Q. Mohamed, P H. Scanlon, J N. Kirkpatrick, and R L. Johnston. Which Visual Acuity Measurements Define High-quality Care for Patients With Neovascular Age-related Macular Degeneration Treated With Ranibizumab? Nature Publishing Group, 2013.

Ross, A H., et al. Which Visual Acuity Measurements Define High-quality Care for Patients With Neovascular Age-related Macular Degeneration Treated With Ranibizumab? Nature Publishing Group, 2013.